Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Acrixolimab by Y-Biologics for Thyroid Cancer: Likelihood of Approval
Acrixolimab is under clinical development by Y-Biologics and currently in Phase II for Thyroid Cancer. According to GlobalData, Phase II...
Data Insights
Acrixolimab by Y-Biologics for Kidney Cancer (Renal Cell Cancer): Likelihood of Approval
Acrixolimab is under clinical development by Y-Biologics and currently in Phase II for Kidney Cancer (Renal Cell Cancer). According to...